PLSM on Nasdaq

Pulsenmore Ltd.

Pulsenmore Ltd. is a surgical and medical instruments and apparatus company based in Omer.1 Its shares trade on Nasdaq under the symbol PLSM.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with NEXGEL, INC., ALLURION TECHNOLOGIES, INC. or WORK Medical Technology Group LTD, or pick any stock.

  • TickerPLSM on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersL31
  • Incorporated inIsrael2
  • Business addressOmarim 8, Omer, Israel, 84965002
  • Filer categoryNon-accelerated filer, Emerging growth company2
  • Legal formCorporation

Our ordinary shares have been listed on the Nasdaq since January 21, 2026 under the symbol “PLSM”.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

84.2%Gross margin4
-39.6%Net margin4
-19.1%Return on equity4
-$10.3MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue16¢$2.0M
  • Research and development43¢$5.4M
  • Other costs23¢$2.9M
  • Interest18¢$2.3M
  • Income tax0¢$1.0K

Out of $12.5M in revenue.4 The company lost money this year.

Financial statements

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
Revenues9.5M ILS9.7M ILS6.2M ILS
Revenues from settlement agreement with GEHC (*)30.5M ILS
Total revenues40.0M ILS9.7M ILS6.2M ILS
Cost of revenues6.3M ILS6.1M ILS4.0M ILS
Gross profit33.7M ILS3.6M ILS2.2M ILS
Research and development expenses, net17.4M ILS20.1M ILS31.4M ILS
Sales and marketing expenses11.8M ILS10.3M ILS9.4M ILS
General and administrative expenses16.7M ILS15.3M ILS17.0M ILS
Operating loss12.2M ILS42.2M ILS55.6M ILS
Financial expenses7.2M ILS540.0K ILS16.2M ILS
Financial income-3.5M ILS-6.0M ILS-13.4M ILS
Financial expenses (income), net3.7M ILS-5.4M ILS2.9M ILS
Loss before income tax15.9M ILS36.8M ILS58.4M ILS
Provision (benefit) for income tax1.0K ILS-56.0K ILS127.0K ILS
Net loss and comprehensive loss15.9M ILS36.7M ILS58.6M ILS
Loss per ordinary share - basic2.46 ILS5.76 ILS9.12 ILS
Loss per ordinary share - diluted2.46 ILS5.76 ILS9.12 ILS

Compare Pulsenmore Ltd. with another company

Corporate structure

Pulsenmore Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Pulsenmore Ltd.

  • Pulsenmore Ltd. L3

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Pulsenmore Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$1.8M4 Dec 31, 2025
Operating-lease assets (leased space)$403.0K4 Dec 31, 2025

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$6.8M4 Dec 31, 2025$12.9M4 Dec 31, 2024−47.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$6.2M4 Dec 31, 2025

Leadership

Who has led Pulsenmore Ltd., and when. Pick a name to see everywhere that person has worked.

Chief financial officer

  1. Eran Hirsh2026–now
Board members and other officers (9)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • VP R&DMenashe Sonnenschein named Jul 7, 202615

Timeline

  1. Mar 18, 2026New chief executive Elazar Sonnenschein becomes CEO5

Filings

50 filings to the SEC since October 2021: 1 annual reports, 12 insider forms, 2 large holders, 1 private raises, 34 other. The latest 20:

  1. Oct 14, 20264 EDGAR
  2. Oct 14, 20263 EDGAR
  3. Oct 13, 20266-K EDGAR
  4. Oct 8, 2026SCHEDULE 13G EDGAR
  5. Sep 17, 20266-K EDGAR
  6. Sep 8, 20266-K EDGAR
  7. Sep 1, 2026EFFECT EDGAR
  8. Aug 31, 2026POS AM EDGAR
  9. Aug 31, 2026S-8 EDGAR
  10. Aug 31, 20266-K EDGAR
  11. Aug 19, 20266-K EDGAR
  12. Aug 17, 20266-K EDGAR
  13. Aug 6, 20266-K EDGAR
  14. Jul 13, 2026424B3 EDGAR
  15. Jul 13, 20266-K EDGAR
  16. Jul 10, 2026EFFECT EDGAR
  17. Jul 7, 2026D EDGAR
  18. Jul 2, 2026F-1 EDGAR
  19. Jul 1, 20266-K EDGAR
  20. Jul 1, 20266-K EDGAR

The 50 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jun 26, 2026Raised $7.5 million in a private offering of securities Form D: 1 investor so far Form D

SEC filer profile

How Pulsenmore Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPulsenmore Ltd.1
  • CIK0002064764
  • Filer statusNon-accelerated filer an emerging growth company; a shell company3
  • Incorporated inIsrael3
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressOmarim 8, Omer, Israel, Israel 8496500, Israel1
  • Phone972 52 606 20751
  • Shares outstanding6,502,844 shares as of Mar 15, 20263
  • AuditorKesselman & Kesselman, Tel-Aviv, Israel PCAOB ID 1309; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceMay 12, 20251
  • Filings50 in all: 6-K (20), 3 (11), DRS/A (4), EFFECT (2), SCHEDULE 13G (2), 20-F (1), 20FR12B (1), 4 (1)1
    All 16 form types

    424B3 (1), CERT (1), D (1), DRS (1), F-1 (1), POS AM (1), S-8 (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (20-F) Mar 30, 2026

Securities registered for trading

ClassSymbolExchange
Ordinary shares, par value NIS 0.00032 per sharePLSMNasdaq

From the cover page of the 20-F filed Mar 30, 2026 (Section 12(b) of the Exchange Act).3